Filter posts

Wall Street Journal Highlights Promising Gene Therapy Advances

Yesterday, bluebird bio reported some very uplifting news at the annual meeting of the American …

Jim Greenwood Op-Ed: Time to Fund Medical Countermeasures against Threats like Ebola

On Friday, The Hill published an op-ed from BIO President and CEO Jim Greenwood calling …

Gates to contribute $50M for Ebola response

Bill Gates was on MSNBC’s Morning Joe to discuss the Gates Foundation’s contribution of $50 …

San Francisco Chronicle: High Drug Co-Pays Deny Needed Treatments

Today, the San Francisco Chronicle published an op-ed that I wrote on the importance of …

Jim Greenwood in WSJ: Curing Hepatitis C Is Cheaper Than Open-Ended Care

On Friday, a letter from BIO President and CEO Jim Greenwood was published in the …

Delivering on Biotech’s Promise to Treat Anthrax, Smallpox, Ebola

Thanks to federal biodefense programs that partner with industry to develop and stockpile medical countermeasures, …

Greenwood Highlights Need for Bold Action to Address Alzheimer's

Last week, Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), participated and …

Jim Greenwood Talks 21st Century Cures with Chairman Fred Upton

Recently, BIO CEO and President Jim Greenwood sat down with House Energy and Commerce Chairman …

Welcome to San Diego!

Welcome to the 2014 BIO International Convention. It has been an exciting and important year …

BIO CEO Lays out Vision for Future of Industrial Biotech

During the opening plenary lunch at BIO’s World Congress on Industrial Biotechnology, Jim Greenwood, President …